Group items tagged

Why has this study not received major press?  Study finds that 10+ year users of statin therapies have an 83% increased risk of invasive ductal carcinoma of the breast, a 97% increase in invasive lobular carcinoma of the breast.  In women with elevated cholesterol, the data gets worse.  There is a 204% increased risk of invasive ductal carcinoma of the breast and a 243% increased risk of invasive lobular carcinoma of the breast in women with elevated lipids and on statins 10+ years.  No matter how  you try to slice this data, this is not good news for a large sub set of women.

Very nice study.  The authors looked at normal prostate, early disease and late stage prostate cancer.  The authors found that ER beta expression, as a general rule, was lost as progression occurred to the high-grade dysplasias and grad 4/5 carcinomas of the prostate.  Early low/moderate dysplasia was associated with an increase in ER beta--the authors propose that this was due to an attempt of the basal epithelium to counter the paracrine effect of ER alpha.   In contrast, androgen receptors appeared to be equally expressed across all.

HDIVC plus mistletoe SQ improved and stabilized a patient with advanced hepatocellular carcinoma.

adenoid cystic carcinoma abstract.

good review of adenoid cystic carcinoma

Case study of DCA in renal cell carcinoma.

Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden

Study finds a reduction in SuperOxide Dismutase and Glutathione Perioxidase in advancing breast cancer.  Cancer is a high oxidative stress disease that results in inflammation, mitochondrial dysfunction and proliferation.  Adenosine Deaminase (ADA) is proposed to be another biomarker to assess tumor stage.  

"Glutathione reductase activity is lower in all colorectal carcinoma groups than in control, and a significant decrease in glutathione reductase activity was obtained between patients in tumor stage II and III compared to tumor stage IV." Same is see with SOD in study.

Study finds 12 g/day BCAA reduced the incidence of hepatocellular carcinoma in those patients with HCV.

Progestins increase insulin receptor content and insulin stimulation of growth in human breast carcinoma cells.

milk thistle shows anti-cancer effect in prostate, breast, and cervical cancers

TK-1 is a proliferation biomarker of DNA repair. TK-1 is a nuclear biomarker of cancer prognosis, survival, recurrence and predicts risk of progression of pre-malignant disease.

published ahead of print.  The authors conclude that the Testosterone therapy in hypogonadal men with cirrhosis requires further study.  They, the authors, state that the risk of Testosterone and hepatocellular carcinoma is overstated.  This risk is associated with oral Testosterone replacement and thus in that light is not overstated.  The majority of treatment strategies today employ none oral routes of administration which would support their statement.

In vitro studies confirm reduced viability of melanoma, rhabdomyoscarcoma, gastric adenocarcinoma, lun carcinoma, and pancreas adenocarcinoma cells with the use of the oncolytic RIGVIR virus

Great review of the synergy of IV vitamin C and ALA in this case study.

Ivermectin, a common anti-parasitic, found to inhibit WTF-TCF pathway and decrease c-terminal phosophorylaiton of Beta-CATENIN all resulting in increased aptosis and inhibition of cancer growth in colon cancer cell lines and lung cancer cell lines.

Animal study finds that DCA reduced renal cell proliferation triggering apoptosis via pyruvate dehydrogenase kinase inhibition.

Older study, 1995, but shows the long-standing evidence that IVC preferentially is cytotoxic to cancer cells.`

Tumor xenograft model in mice finds reduction in growth rates of ovarian cancer, pancreatic cancer, and glioblastoma with daily IV vitamin C.